SEQIRUS
SEQIRUS
Social Links:
Industry:
Pharmaceutical
Founded:
1916-01-01
Address:
Dandenong Road, Victoria, Australia
Country:
Australia
Website Url:
http://www.seqirus.com.au
Total Employee:
1001+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Google Maps JsDelivr
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.seqirus.com.au Semrush global rank: 3.46 M Semrush visits lastest month: 4.39 K
- Host name: csl.com
- IP address: 12.3.33.229
- Location: Atlanta United States
- Latitude: 33.9707
- Longitude: -84.3247
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30338
More informations about "Seqirus"
Global Biotechnology Company - CSL
At CSL Seqirus, we stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world. As a global vaccine leader, our …See details»
SEQIRUS PTY LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SEQIRUS PTY LTD of Melbourne, VICTORIA. Get the latest business insights from Dun & Bradstreet.See details»
SEQIRUS HOLDINGS AUSTRALIA PTY. LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for SEQIRUS HOLDINGS AUSTRALIA PTY. LTD. of MELBOURNE, VICTORIA. Get the latest business …See details»
We Are CSL | CSL
CSL Seqirus, one of the largest influenza vaccine providers in the world; and, CSL Vifor, a leader in iron deficiency and nephrology. Together, our combined and robust histories are delivering …See details»
CSL Limited - Wikipedia
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma …See details»
CSL Seqirus | About Us
But at CSL Seqirus, we believe it shouldn’t be that way. As the only vaccine company with a singular global focus on influenza, we work tirelessly on cutting-edge research, transformative technologies and the latest methods of …See details»
Working at CSL Seqirus company profile and information - SEEK
Seqirus, formerly bioCSL, manufactures and in-licenses, markets and distributes vaccines with particular focus on vaccines for the prevention and treatment of serious disease. We operate …See details»
News Releases - CSL
Please be aware that information relating to the approval status and labels of approved CSL Seqirus products may vary from country to country. Please consult your local regulatory …See details»
Australian Securities Exchange Seqirus Presentation to …
Seqirus Presentation to Investors/Analysts . Please see attached presentation to investors/analysts given by: • Gordon Naylor, President, Seqirus • Russell Basser, SVP R&D, …See details»
News Releases - CSL
May 30, 2024 CSL Seqirus to provide 665,000 pre-pandemic (zoonotic) vaccines to support fifteen EU and EEA Member States. Outbreaks of highly pathogenic avian influenza (HPAI) …See details»
Global Biotechnology Company | CSL
CSL Seqirus. Global Vaccine Leader. Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public …See details»
News Releases - CSL
Nov 16, 2020 Seqirus is a wholly owned subsidiary of CSL Limited, which will invest more than AUD$800 million in capital expenditure to construct the facility. The building is expected to be …See details»
A Milestone for an Australian Vaccine Facility - CSL
Jun 16, 2023 CSL Seqirus, a business unit of CSL, recently celebrated the construction milestone known as “topping out,” which marks the completion of the highest point in a …See details»
Australia injects $1 billion into new flu vaccine facility
Nov 16, 2020 The federal government’s current deal with Seqirus had been due to expire in 2024-25, potentially putting Australia at risk of needing to source critical medical products from …See details»
Seqirus, a Business of CSL Limited, Announces New Facility …
SUMMIT, N.J., Feb. 7, 2022 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and a business of CSL Limited (ASX:CSL), today announced an investment in a new Research …See details»
Behind the Business at Seqirus: Protecting People From Another …
Nov 4, 2021 In addition to prioritizing active listening across the organization, Seqirus hosted multiple COVID-19 vaccine clinics at their Holly Springs facility and have provided more than …See details»
Scientist I Job in Holly Springs, NC | CareerBuilder.com
Seqirus has an exciting opportunity to join our expanding team in Holly Springs, NC. With an advanced manufacturing facility and expertise in influenza science we are one of the world …See details»
Vaccines - CSL
Developing new influenza vaccines across all age groups in expanded markets is a strategic priority for CSL Seqirus, including further advancing our cell-based manufacturing technology …See details»
Guess Who Profits From Trump’s Deportation Plan? Private Equity …
6 hours ago Trump’s promised mass deportation campaign will enrich private equity companies, according to a new report released Wednesday by a watchdog organization tracing the …See details»
Pandemic Response - CSL
Pictured: CSL Seqirus researcher in the lab in Massachusetts, USA. A Comprehensive Portfolio of Solutions. We offer a portfolio of pre-pandemic and pandemic influenza vaccines through …See details»